Abstract: The present invention relates to method of preventing, treating or attenuating obesity-related manifestations in a human or non-human mammal subject in need thereof, said method comprising orally administering to the subject a composition comprising an effective amount Hafnia alvei probiotics; wherein said obesity-related parameters are selected from the group of hyperphagia, increased fat mass on lean mass ratio, increased waist circumference, postprandial hyperglycemia, fasting hyperglycemia and hypercholesterolemia.

Abstract: An automated flight control functional testing system includes a first sensor on a pilot input device for sensing position of the pilot input device, and a distributed network of sensors on a plurality of control surfaces of an aircraft for sensing positions of the control surfaces. A controller determines an expected position of each control surface based on data signals received from the first sensor, and the controller determines an actual position of each control surface based on data signals received from the distributed network of sensors. An automated flight control functional testing method includes transmitting angle information to a controller from a first angle sensor on a pilot input device and a second angle sensor on a control surface of an aircraft, and comparing an expected angle of a control surface based on the first sensor with an actual angle of the control surface based on the second sensor.

Abstract: Methods of treating inflammation, in particular obesity, inducing satiation, prolonging satiety, and stimulating weight loss in a subject in need thereof, including the administration of a Brassicaceae protein extract. The Brassicaceae protein extract may be administered in the form of a dietary supplement or a food composition, either of which may include at least one additional ingredient.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of Hafnia alvei.

Abstract: Method and system for carrying out all the transactions performable at an ATM, with the exception of provision of cash, by means of a mobile telecommunications device, specifically a third generation (3G) mobile telephone and the UMTS network. The system comprises the modules (2, 4, 5) necessary for securely carrying out said transactions, by means of access to the ATM by using a virtual emulation thereof, and outside existing networks and protocols now used for these types of transactions.

Abstract: The invention relates to a method for processing aluminum in a furnace consisting in introducing an aluminum-containing material and possibly one or several types of salt into the furnace, melting said material by heating with the aid of at least one burner supplied with a combustive material and fuel in such a way that a molten aluminum possibly covered with a slag containing, in particular alumina and at least one salt is produced and in measuring a carbon monoxide and/or hydrogen concentration in the furnace atmosphere or in a smoke at the exit of the furnace. Oxygen content in the combustive material supplying at least one burner is greater than 10% by volume, preferably greater than 21% by volume.

Abstract: The invention relates to a method for processing aluminum in a furnace consisting in introducing an aluminum-containing material and possibly one or several types of salt into the furnace, melting said material by heating with the aid of at least one burner supplied with a combustive material and fuel in such a way that a molten aluminum possibly covered with a slag containing, in particular alumina and at least one salt is produced and in measuring a carbon monoxide and/or hydrogen concentration in the furnace atmosphere or in a smoke at the exit of the furnace. Oxygen content in the combustive material supplying at least one burner is greater than 10% by volume, preferably greater than 21% by volume.

Abstract: A method is disclosed for detecting abnormal epitope expression of protein molecules by immunocapturing a constant number of protein molecules from a test and a reference sample using a limited amount of capturing antibodies, saturating them with its corresponding protein from the test and reference samples to provide a constant, known amount of the immobilized protein for comparison, labelling an epitope on the immobilized protein by means of a labelled probing antibody specifically reactive with the epitope and correlating any difference in labelling between the test and the reference sample to the absence or modification of the epitope in the protein of the test sample.

Abstract: Disclosed are methods that permit the determination of both lipid moiety (LM) and apolipoprotein expressed epitope immunoreactivity (EEI) of intact isolated lipoprotein species. One format of the method isolates a lipoprotein species by means of a ligand binding to a solid phase, and quantitates thereafter the LM and/or the EEI. A complementary variant format provides for nonquantitative study of a constant number of lipoprotein particles exploring the sizes of the particles (LM) and scanning the apolipoprotein epitopes (EEI). Disclosed also is a method using lipid moiety dynamics (LMD) and expressed epitopes immunoreactivity dynamics (EEID) to explore the lipid loading and unloading of the lipoprotein species during a fast-feeding cycle. Both the LMD and EEID of lipoprotein particles may be performed as a panel, individual or in any combination. This can be used to detect abnormalities in lipid metabolism that precede the hyperlipidemias associated with cardiovascular disease.